HWM
TWST icon

HighMark Wealth Management’s Twist Bioscience TWST Stock Holding History

HighMark Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.02M Sell
39,030
-260
-0.7% -$16.9K 1.35% 15
2026
Q1 		$1.87M Sell
39,290
-172
-0.4% -$7.71K 0.76% 20
2025
Q4 		$1.25M Hold
39,462
– – 0.51% 28
2025
Q3 		$1.11M Buy
39,462
+947
+2% +$28.7K 0.49% 28
2025
Q2 		$1.42M Buy
38,515
+38,200
+12,127% +$1.32M 0.69% 20
2025
Q1 		$12.4K Buy
315
+100
+47% +$4.5K 0.01% 251
2024
Q4 		$9.99K Buy
+215
New +$9.72K 0.01% 288

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

HighMark Wealth Management's TWST Position: Q2 2026 in Review

HighMark Wealth Management reduced its Twist Bioscience (TWST) stake by 0.66% in Q2 2026, selling an estimated $16.9K and leaving 39,030 shares worth $4.02M. The position accounts for 1.35% of the portfolio, ranked #15.

HighMark Wealth Management first reported a position in TWST in Q4 2024 and has held it in 7 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • HighMark Wealth Management held 39,030 shares of Twist Bioscience worth $4.02M as of Q2 2026.
  • HighMark Wealth Management sold 260 Twist Bioscience shares in Q2 2026, an estimated $16.9K.
  • Twist Bioscience made up 1.35% of HighMark Wealth Management's portfolio in Q2 2026, its #15 holding.
  • HighMark Wealth Management first reported a position in Twist Bioscience in Q4 2024 and has held it in 7 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.